Subscribe
e-paper Podcasts IFSC Code Finder New
e-paper
OPEN APP
Home >Companies >Company Results >Biocon Q3 net profit falls 19% to Rs186.6 crore

Biocon Q3 net profit falls 19% to Rs186.6 crore

Biocon had hived off its biosimilars division into Biocon Biologics in March 2019.

The company's revenue from operations rose to 1,851 crore for the quarter under consideration, up 7.81%, as against 1,716.8 crore during the same period a year ago, Biocon said

Biotechnology major Biocon has reported an 18.97% fall in consolidated profit at 186.6 crore for the quarter ended December 31, 2020 on account of higher expenses.

Biotechnology major Biocon has reported an 18.97% fall in consolidated profit at 186.6 crore for the quarter ended December 31, 2020 on account of higher expenses.

The company had posted a profit of 230.3 crore for the corresponding period of the previous fiscal.

The company had posted a profit of 230.3 crore for the corresponding period of the previous fiscal.

Subscribe to Continue Reading

The company's revenue from operations rose to 1,851 crore for the quarter under consideration, up 7.81%, as against 1,716.8 crore during the same period a year ago, Biocon said in a late night regulatory filing on Thursday.

Expenses rose to 1,642.6 crore for the December quarter, an increase of 14.52%, as against 1,434.3 crore in the year-ago period.

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, said: "2020 has been one of the most challenging years for the world with an unprecedented pandemic impact on the global economy. We continue to face headwinds across operational, regulatory and commercial functions which have been deterrents to our planned market expansion. However, we expect normalisation by next fiscal".

Shares of Biocon Ltd were trading 8.44% lower at 404.64 apiece on the BSE.

Click here to read the Mint ePaper
Mint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.